SCHEDULE 13G/A: BlackRock Amends Significant Stake in iShares Global Healthcare ETF to 22.5%

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 22.5% beneficial ownership stake in iShares Global Healthcare ETF as of March 31, 2025.

Summary

• BlackRock, Inc. has filed Amendment No. 6 to its Schedule 13G, reporting its beneficial ownership in ISHARES GLOBAL HEALTHCARE ETF.
• As of March 31, 2025, BlackRock, Inc. beneficially owns 9,755,630 shares of Common Stock, which represents 22.5% of the total class outstanding.
• BlackRock, Inc. holds sole voting power and sole dispositive power over all 9,755,630 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• BlackRock Investment Management (Australia) Limited, a subsidiary of BlackRock, Inc., is identified as an entity that beneficially owns 5% or greater of the outstanding shares of the security class.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing disclosing passive ownership, containing no inherently positive or negative news for the issuer or the reporting entity beyond standard compliance.

Positives

• BlackRock's continued significant stake (22.5%) in the iShares Global Healthcare ETF may signal ongoing confidence in the healthcare sector or the ETF's investment strategy.
• The filing confirms that BlackRock's ownership is for ordinary course of business and not for control purposes, which can provide stability regarding the ETF's management and strategic direction.

Future Outlook

This document does not contain any forward-looking statements or guidance regarding the issuer or BlackRock's future investment plans.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

BlackRock, as one of the world's largest asset managers, routinely files Schedule 13G reports to disclose its passive ownership stakes in various ETFs and public companies. This filing is consistent with its operational model within the financial services industry, reflecting its role in managing diverse investment portfolios for its clients.

Comparison to Industry Standards

• This filing is a standard regulatory disclosure for institutional investors holding over 5% of a company's shares, aligning with SEC requirements for transparency in significant ownership stakes.
• No specific comparable companies, projects, or results are mentioned within the document to allow for a detailed comparison of the iShares Global Healthcare ETF's performance or BlackRock's investment strategy against industry benchmarks.

Related Party Transactions

• BlackRock Investment Management (Australia) Limited, a direct or indirect subsidiary of BlackRock, Inc. (the reporting person), is identified as beneficially owning 5% or greater of the outstanding shares of ISHARES GLOBAL HEALTHCARE ETF.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, confirming passive investment intent and potentially offering a signal of confidence in the ETF.
• Employees, Customers, Suppliers, Creditors: No direct impact is indicated by this routine ownership disclosure.

Key Dates

Keywords

BlackRock, ISHARES GLOBAL HEALTHCARE ETF, Schedule 13G, Beneficial Ownership, ETF, Healthcare, Investment Management, Institutional Investor, Passive Investment